Business Context and Reporting Period
Company: Capricor Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 28, 2019
Reporting Period: The filing announces financial results for the quarter and full year ended December 31, 2018.
Key Financial Metrics
The provided text serves as a cover document referencing a press release (Exhibit 99.1) containing the actual financial data. The filing text itself does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing text does not contain specific comparative data or details regarding material changes versus the prior comparable period. It only indicates that such results were announced in the attached press release.
Guidance, Outlook, and Risks
The filing references a press release titled "Capricor Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update." While the title suggests the presence of a corporate update, the specific content regarding guidance, outlook, management commentary, risks, or unusual items is not included in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (the attached press release) for specific revenue, net loss, and cash position figures for Q4 and Full Year 2018.
- Verify the "Corporate Update" section in the press release for clinical trial progress or strategic shifts.
- Confirm the company's cash runway and any recent financing activities mentioned in the full press release.
- Check for any forward-looking statements or guidance updates regarding 2019 operations.